• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ReShape Lifesciences, Inc. - Common Stock (NQ:RSLS)

3.920 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ReShape Lifesciences, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow
August 14, 2025
From Vyome Therapeutics, Inc. and ReShape Lifesciences Inc.
Via Business Wire
News headline image
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
August 13, 2025
From ReShape Lifesciences
Via Business Wire
News headline image
Vyome Announces New Board of Directors with Deep MIT and AI Ties
August 12, 2025
From Vyome Therapeutics and ReShape Lifesciences
Via Business Wire
News headline image
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
August 07, 2025
From ReShape Lifesciences
Via Business Wire
News headline image
ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders
July 24, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit
July 22, 2025
Company to Host Pre-Eminent Lap-Band® Surgeon Advocates For a Three-Day Seminar, August 1-3, 2025 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025
July 21, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System
July 01, 2025
Patent Enhances and Broadens the Company’s Intellectual Property Portfolio Around a Swallowable and Degradable Intragastric Device 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement
June 27, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys
June 26, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology
June 25, 2025
Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
AI & Tech Breakout: PRSO, IPA, NEHC, SOAR Lead Today’s Innovation Surge – More Movers Inside
June 12, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets
June 12, 2025
Recon Supply Named Exclusive U.S. Distributor of ReShape’s STIMEL-03, Lap-Band® 2.0 FLEX, and Full Product Portfolio to Reach U.S. Veterans and Active-Duty Service Members 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering
June 09, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio
June 03, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update
May 21, 2025
Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys Progress Towards Completion 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences Announces 1-for-25 Reverse Stock Split
May 07, 2025
Effective as of Commencement of Trading on May 9, 2025 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
May 02, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System
April 28, 2025
Patent Expands and Strengthens Intellectual Property Portfolio Around a Swallowable and Degradable Intragastric Device 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
April 21, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market
April 09, 2025
ReShape Enters Exclusive U.S. Distribution Agreement in the Neuromuscular Rehabilitation Market 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update
April 07, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
Power Nickel (TSX.V: PNPN) – Undervalued Precious, Battery, Energy and Base Metals Play Amidst Gold Surge – More Stocks Inside
April 01, 2025
Via AB Newswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AVTE, RSLS on Behalf of Shareholders
March 23, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLS
March 21, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
March 10, 2025
Vagal Neuromodulation Provides Route to Treat Type 2 Diabetes and Hypoglycemia 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX
February 25, 2025
Liaison Medical is Among the Largest Surgical Device Distributors in Canada 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering
February 15, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology
February 03, 2025
Vagal Neuromodulation Provides Path to Treat Type 2 Diabetes and Hypoglycemia 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
January 13, 2025
Transactions Continue to Progress and Remain on Track 
From ReShape Lifesciences Inc
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap